How the Microbiome Alters Drug Metabolism
Speaker:
Jennifer Reinhart, DVM, PhD, DACVIM (SAIM), DACVCP
Event date: 6–7 November 2024 Virtual Event
Veterinarians generally accept that many drugs affect the gut microbiome. But what about the reverse: How does the intestinal microbiome impact the pharmacokinetics and pharmacodynamics of administered drugs?
The relationships between drug, microbiome, and host/patient are complex. Dr. Jennifer Reinhart introduces veterinary professionals to pharmacomicrobiomics, an emerging and important component of personalized medicine. Researchers now recognize the gut microbiota, with its large metabolic capacity, contributes to interindividual variation in host/patient response to drugs.
Related Content
Microbiome Shifts in Canine and Feline Health and Disease
Shifts in gut microbiota taxa and/or diversity can result in functional changes in the microbiome. Learn why early recognition of microbiome shifts may improve management of patients with GI conditions.
Day 2 Panel Discussion and Closing Remarks
The speakers who presented lectures during Day 2 of the Purina Institute Microbiome Forum 2024 join Dr. Jan Suchodolski to answer questions submitted by audience members.
Part of the whole: the role of the gut microbiome in host health
Learn how the gut microbiome is a metabolic and immunologic organ that plays an important role in health and disease. Dr. Suchodolski also explores the relationship between the microbiota, dysbiosis and systemic organ disease.